![Bretton Goods artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts115/v4/2d/16/40/2d16400d-5539-df38-d92b-7ba5d9b115e9/mza_4183091861653125162.jpg/100x100bb.jpg)
Ep. 50: mRNA vaccines in India ft. Soham Sankaran
Bretton Goods
English - August 21, 2023 07:35 - 1 hour - 32 MB - ★★★★★ - 1 ratingSocial Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
I spoke to Soham Sankaran who runs PopVax, an Indian mRNA vaccine company. Their goal is to build low-cost broadly-protective vaccines to protect against the entire sarbecovirus species. Read Soham's experience here (https://chronicles.popvax.com/p/three-meetings-and-six-million-funerals) as a complement to this episode. Also check out their jobs page (https://jobs.popvax.com/) for opportunities.
This episode includes
How he started PopVax and (went bankrupt in the process)
Why there hasn't been a successful Indian mRNA vaccine yet
Why developing countries can't afford drugs for rare diseases
What they're doing to fix it
Their biggest constraints
---
Send in a voice message: https://podcasters.spotify.com/pod/show/pradyumna-sp/message